Evidence map›Paper›PMID 36833477›Full record

ArticleInternational journal of environmental research and public health2023

Change over Time in the Risk of Death among Japanese COVID-19 Cases Caused by the Omicron Variant Depending on Prevalence of Sublineages.

Yuki Takahashi, Hideo Tanaka, Yoshitaka Koga, Shunichi Takiguchi, Shigeru Ogimoto, Shizuyo Inaba, Hiroyuki Matsuoka, Yuka Miyajima, Takeshi Takagi, Fujiko Irie and 12 more

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Mortality in Germany during the COVID-19 Pandemic.International journal of environmental research and public health · 2023
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Yuki TakahashiFujiidera Public Health Center of Osaka Prefectural Government, Fujiidera 583-0024, Japan.
Hideo TanakaNeyagawa City Public Health Center, Neyagawa 572-0838, Japan.
Yoshitaka KogaTosu Public Health and Welfare Office of Saga Prefectural Government, Tosu 841-0051, Japan.
Shunichi TakiguchiCentral Public Health Center of Miyazaki Prefectural Government, Kirishima 880-0032, Japan.
Shigeru OgimotoMiyoshi Public Health Center of Tokushima Prefectural Government, Mima 778-0002, Japan.
Shizuyo InabaGifu Public Health Center of Gifu Prefectural Government, Gifu 504-0838, Japan.
Hiroyuki MatsuokaIida Public Health Center of Nagano Prefectural Government, Iida 395-0034, Japan.ORCID 0000-0001-8839-0012
Yuka MiyajimaMatsumoto Public Health Center of Nagano Prefectural Government, Matsumoto 390-0852, Japan.
Takeshi TakagiIsesaki Public Health Center of Gunma Prefectural Government, Isesaki 372-0024, Japan.
Fujiko IrieTsuchiura Public Health Center of Ibaraki Prefectural Government, Tsuchiura 300-0812, Japan.
Yoshihito BambaIbaraki Prefectual Department of Public Health and Welfare, Mito 310-8555, Japan.
Fuyo YoshimiCentral Public Health Center of Ibaraki Prefectural Government, Mito 310-0852, Japan.
Tomoyuki SuzukiShiga Prefectural Department of Public Health Care and Welfare, Otsu 520-8577, Japan.
Isao ArakiShiga Prefectural Health, Medical and Welfare Department, Otsu 520-8577, Japan.
Chika ShiraiHirakata City Public Health Center, Hirakata 573-0027, Japan.
Sayuri MatsumotoHigashiosaka City Public Health Center, Higashiosaka 578-0941, Japan.ORCID 0000-0002-2023-4272
Motoyuki ShimizuHigashiosaka City Public Health Center, Higashiosaka 578-0941, Japan.
Toshiyuki ShibataSuita City Public Health Center, Suita 564-0072, Japan.
Hitomi NagaiIbaraki Public Health Center of Osaka Prefectural Government, Ibaraki 567-8585, Japan.
Masaru KinoshitaFujiidera Public Health Center of Osaka Prefectural Government, Fujiidera 583-0024, Japan.
Rie FujitaKenou Public Health Center of Nagasaki Prefectural Government, Isahaya 854-0081, Japan.
Tsuyoshi OgataItako Public Health Center of Ibaraki Prefectural Government, Itako 311-2422, Japan.ORCID 0000-0002-3261-888X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To assess temporal changes to the risk of death in COVID-19 cases caused by the Omicron variant, we calculated age-standardized case fatality rates (CFR) in patients aged ≥40 years over nine diagnostic periods (3 January to 28 August 2022) in ten Japanese prefectures (14.8 million residents). Among 552,581 study subjects, we found that there were 1836 fatalities during the isolation period (up to 28 days from date of onset). The highest age-standardized CFR (0.85%, 95% confidence interval (CI):0.78-0.92) was observed in cases diagnosed in the second 4-week period (January 31 to February 27), after which it declined significantly up to the 6th 4-week period (0.23%, 95% CI: 0.13-0.33, May 23 to June 19). The CFR then increased again but remained at 0.39% in the eighth period (July 18 to August 28). The CFR in cases with the BA.2 or BA.5 sublineages in the age range 60-80 years was significantly lower than that with BA.1 infections (60 years: 0.19%, 0.02%, 0.053%, respectively; 70 years: 0.91%, 0.33%, 0.39%; ≥80 years: 3.78%, 1.96%, 1.81%, respectively). We conclude that the risk of death in Japanese COVID-19 patients infected with Omicron variants declined through February to mid-June 2022.

Indexed as

COVID-19East Asian PeopleAgedAged, 80 and overHumansMiddle AgedPrevalenceSARS-CoV-2case fatality rateJapaneseOmicron variantSARS-CoV-2

Identifiers

PMID36833477
PMCPMC9957287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.